Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening

Journal of Genetic Counseling

Volumn 24, Issue 3, 2015, Pages 381-387

  Grinzaid, Karen Arnovitz ^a   Page, Patricia Zartman ^a   Denton, Jessica Johnson ^a   Ginsberg, Jessica ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carrier; Genetic; Jewish; Reproductive; Screening

Indexed keywords

CHILD; FEMALE; GENETIC COUNSELING; GENETIC DISEASES, INBORN; GENETIC SCREENING; GENETICS; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMAN; JEW; MASS SCREENING; NONBIOLOGICAL MODEL; PREGNANCY; PROCEDURES; SALIVA; UNITED STATES;

CHILD; FEMALE; GENETIC COUNSELING; GENETIC DISEASES, INBORN; GENETIC TESTING; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; JEWS; MASS SCREENING; MODELS, ORGANIZATIONAL; PREGNANCY; SALIVA; UNITED STATES;

EID: 84939960192     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-014-9800-x     Document Type: Article

References (13)

1. Castellani, C., Perobelli, S., Bianchi, V., Seia, M., Melotti, P., Zanolla, L., & Lalatta, F. (2011). An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. American Journal of Medical Genetics Part A, 155(4), 778–785. doi:10.1002/ajmg.a.33870.
2. Chen, L.-S., & Goodson, P. (2007). Factors affecting decisions to accept or decline cystic fibrosis carrier testing/screening: a theory-guided systematic review. Genetics in Medicine, 9(7), 442–450.
3. Consortium, Jewish Genetic Disease. Jewish Genetic Diseases. Retrieved 11/20/2013, from http://www.jewishgeneticdiseases.org/jewish-genetic-diseases/.
4. Darcy, D, Tian, L., Taylor, J., & Schrijver, I. (2011). Cystic fibrosis.Carrier screening in obstetric clinical practice: Knowledge, practices, and barriers, a decade after publication of screening guidelines. Genetic testing and molecular biomarkers.
5. Genetics, ACOG Committee Genetics on. (2009). ACOG committee opinion No. 442: preconception and prenatal carrier screening for genetic diseases in individuals of eastern European Jewish descent. Obstetrics and Gynecology, 114(4), 950–953.
6. Gross, S. J., Pletcher, B. A., & Monoghan, K. G. (2008). Carrier screening in individuals of Ashkenazi Jewish descent. Genetics in Medicine, 10(1), 55–56.
7. Hoffman, J. D., Greger, V., Strovel, E. T., Blitzer, M. G., Umbarger, M. A., Kennedy, C., & Towne, C. (2013). Next-generation DNA sequencing of HEXA: a step in the right direction for carrier screening. Molecular Genetics & Genomic Medicine, 1(4), 260–268. doi:10.1002/mgg3.37.
8. Janssens, S., Paepe, A., & Borry, P. (2012). Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature. Journal of Community Genetics, 1–17. doi: 10.1007/s12687-012-0131-z.
9. Kaback, M. M. (2000). Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. European Journal of Pediatrics, 159(Suppl 3), S192–S195.
10. Klitzman, R., Chung, W., Marder, K., Shanmugham, A., Chin, L. J., Stark, M., & Appelbaum, P. S. (2013). Attitudes and practices among internists concerning genetic testing. Journal of Genetic Counseling, 22(1), 90–100. doi:10.1007/s10897-012-9504-z.
11. Klugman, S., & Gross, S. J. (2010). Ashkenazi Jewish screening in the twenty-first century. Obstetrics and Gynecology Clinics of North America, 37(1), 37–46. doi:10.1016/j.ogc.2010.01.001.
12. Schneider, A., Nakagawa, S., Keep, R., Dorsainville, D., Charrow, J., Aleck, K., & Gross, S. (2009). Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing. American Journal of Medical Genetics Part A, 149A(11), 2444–2447. doi:10.1002/ajmg.a.33085.
13. The Pew Research Center's Internet & American Life Project. (2013). Retrieved 12/10/2013, from http://www.pewinternet.org/Commentary/2011/November/Pew-Internet-Health.aspx.